Steven E. Shoelson, MD, PhD - Publications

Affiliations: 
Joslin Diabetes Center  Harvard University, Cambridge, MA, United States 
Area:
insulin resistance and type 2 diabetes. Structural biology of diabetes and insulin resistance.
Website:
http://www.joslinresearch.org/pinet/InvestigatorDetail.asp?InvestigatorID=24

139 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Kim OH, Kang GH, Hur J, Lee J, Jung Y, Hong IS, Lee H, Seo SY, Lee DH, Lee CS, Lee IK, Bonner-Weir S, Lee J, Park YJ, Kim H, ... Shoelson SE, et al. Externalized phosphatidylinositides on apoptotic cells are eat-me signals recognized by CD14. Cell Death and Differentiation. PMID 35017647 DOI: 10.1038/s41418-022-00931-2  0.755
2017 Zhang N, Valentine JM, Zhou Y, Li ME, Zhang Y, Bhattacharya A, Walsh ME, Fischer KE, Austad SN, Osmulski P, Gaczynska M, Shoelson SE, Van Remmen H, Chen HI, Chen Y, et al. Sustained NFκB inhibition improves insulin sensitivity but is detrimental to muscle health. Aging Cell. PMID 28556540 DOI: 10.1111/Acel.12613  0.397
2017 Woo JR, Kim SJ, Kim KY, Jang H, Shoelson SE, Park S. The carboxy-terminal region of the TBC1D4 (AS160) RabGAP mediates protein homodimerization. International Journal of Biological Macromolecules. PMID 28545963 DOI: 10.1016/J.Ijbiomac.2017.05.119  0.367
2017 Salastekar N, Desai T, Hauser T, Schaefer EJ, Fowler K, Joseph S, Shoelson S, Goldfine AB. Salsalate Improves Glycemia in Overweight Persons With Diabetes Risk Factors of Stable Statin-Treated Cardiovascular Disease: a 30-month Randomized Placebo-Controlled Trial. Diabetes, Obesity & Metabolism. PMID 28295931 DOI: 10.1111/Dom.12940  0.357
2017 Goldfine AB, Shoelson SE. Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk. The Journal of Clinical Investigation. 127: 83-93. PMID 28045401 DOI: 10.1172/Jci88884  0.344
2016 Hauser TH, Salastekar N, Schaefer EJ, Desai T, Goldfine HL, Fowler KM, Weber GM, Welty F, Clouse M, Shoelson SE, Goldfine AB. Effect of Targeting Inflammation With Salsalate: The TINSAL-CVD Randomized Clinical Trial on Progression of Coronary Plaque in Overweight and Obese Patients Using Statins. Jama Cardiology. 1: 413-423. PMID 27438317 DOI: 10.1001/Jamacardio.2016.0605  0.314
2016 Lee BC, Kim MS, Pae M, Yamamoto Y, Eberlé D, Shimada T, Kamei N, Park HS, Sasorith S, Woo JR, You J, Mosher W, Brady HJ, Shoelson SE, Lee J. Adipose Natural Killer Cells Regulate Adipose Tissue Macrophages to Promote Insulin Resistance in Obesity. Cell Metabolism. PMID 27050305 DOI: 10.1016/J.Cmet.2016.03.002  0.817
2015 Rubin MR, Goldfine AB, McMahon DJ, Donovan DS, Cremers S, Dworakowski E, Schaefer EJ, Shoelson SE, Silverberg SJ. Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitus. Endocrine. PMID 25636441 DOI: 10.1007/S12020-015-0535-8  0.32
2014 Pearce LR, Joe R, Doche ME, Su HW, Keogh JM, Henning E, Argetsinger LS, Bochukova EG, Cline JM, Garg S, Saeed S, Shoelson S, O'Rahilly S, Barroso I, Rui L, et al. Functional characterization of obesity-associated variants involving the α and β isoforms of human SH2B1. Endocrinology. 155: 3219-26. PMID 24971614 DOI: 10.1210/En.2014-1264  0.335
2014 Lee J, Miyazaki M, Romeo GR, Shoelson SE. Insulin receptor activation with transmembrane domain ligands. The Journal of Biological Chemistry. 289: 19769-77. PMID 24867955 DOI: 10.1074/Jbc.M114.578641  0.81
2013 Kim MS, Yamamoto Y, Kim K, Kamei N, Shimada T, Liu L, Moore K, Woo JR, Shoelson SE, Lee J. Regulation of diet-induced adipose tissue and systemic inflammation by salicylates and pioglitazone. Plos One. 8: e82847. PMID 24376593 DOI: 10.1371/Journal.Pone.0082847  0.804
2013 King AJ, Guo Y, Cai D, Hollister-Lock J, Morris B, Salvatori A, Corbett JA, Bonner-Weir S, Shoelson SE, Weir GC. Sustained NF-κB activation and inhibition in β-cells have minimal effects on function and islet transplant outcomes. Plos One. 8: e77452. PMID 24204831 DOI: 10.1371/Journal.Pone.0077452  0.632
2013 Romeo GR, Pae M, Eberlé D, Lee J, Shoelson SE. Profilin-1 haploinsufficiency protects against obesity-associated glucose intolerance and preserves adipose tissue immune homeostasis. Diabetes. 62: 3718-26. PMID 23884883 DOI: 10.2337/Db13-0050  0.81
2013 Goldfine AB, Fonseca V, Jablonski KA, Chen YD, Tipton L, Staten MA, Shoelson SE. Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Annals of Internal Medicine. 159: 1-12. PMID 23817699 DOI: 10.7326/0003-4819-159-1-201307020-00003  0.311
2013 Goldfine AB, Conlin PR, Halperin F, Koska J, Permana P, Schwenke D, Shoelson SE, Reaven PD. A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance. Diabetologia. 56: 714-23. PMID 23370525 DOI: 10.1007/S00125-012-2819-3  0.433
2012 Mima A, Qi W, Hiraoka-Yamomoto J, Park K, Matsumoto M, Kitada M, Li Q, Mizutani K, Yu E, Shimada T, Lee J, Shoelson SE, Jobin C, Rask-Madsen C, King GL. Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes. Investigative Ophthalmology & Visual Science. 53: 8424-32. PMID 23197686 DOI: 10.1167/Iovs.12-10207  0.788
2012 Romeo GR, Lee J, Shoelson SE. Metabolic syndrome, insulin resistance, and roles of inflammation--mechanisms and therapeutic targets. Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 1771-6. PMID 22815343 DOI: 10.1161/Atvbaha.111.241869  0.814
2012 Schakman O, Dehoux M, Bouchuari S, Delaere S, Lause P, Decroly N, Shoelson SE, Thissen JP. Role of IGF-I and the TNFα/NF-κB pathway in the induction of muscle atrogenes by acute inflammation. American Journal of Physiology. Endocrinology and Metabolism. 303: E729-39. PMID 22739109 DOI: 10.1152/Ajpendo.00060.2012  0.335
2012 Cipolletta D, Feuerer M, Li A, Kamei N, Lee J, Shoelson SE, Benoist C, Mathis D. PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature. 486: 549-53. PMID 22722857 DOI: 10.1038/Nature11132  0.825
2012 Haegens A, Schols AM, Gorissen SH, van Essen AL, Snepvangers F, Gray DA, Shoelson SE, Langen RC. NF-κB activation and polyubiquitin conjugation are required for pulmonary inflammation-induced diaphragm atrophy. American Journal of Physiology. Lung Cellular and Molecular Physiology. 302: L103-10. PMID 22003096 DOI: 10.1152/Ajplung.00084.2011  0.304
2012 Wong MC, van Diepen JA, Hu L, Guigas B, de Boer HC, van Puijvelde GH, Kuiper J, van Zonneveld AJ, Shoelson SE, Voshol PJ, Romijn JA, Havekes LM, Tamsma JT, Rensen PC, Hiemstra PS, et al. Hepatocyte-specific IKKβ expression aggravates atherosclerosis development in APOE*3-Leiden mice. Atherosclerosis. 220: 362-8. PMID 21798539 DOI: 10.1016/J.Atherosclerosis.2011.06.055  0.323
2012 Woo JR, Kim S, Shoelson SE, Park SY. X-ray crystallographic structure of TIR-domain from the human TIR-domain containing adaptor protein/MyD88-adaptor-like protein (TIRAP/MAL) Bulletin of the Korean Chemical Society. 33: 3091-3094. DOI: 10.2210/Pdb4Fz5/Pdb  0.309
2011 van Diepen JA, Vroegrijk IO, Berbée JF, Shoelson SE, Romijn JA, Havekes LM, Rensen PC, Voshol PJ. Aspirin reduces hypertriglyceridemia by lowering VLDL-triglyceride production in mice fed a high-fat diet. American Journal of Physiology. Endocrinology and Metabolism. 301: E1099-107. PMID 21862721 DOI: 10.1152/Ajpendo.00185.2011  0.32
2011 Mathis D, Shoelson SE. Immunometabolism: an emerging frontier. Nature Reviews. Immunology. 11: 81. PMID 21469396 DOI: 10.1038/Nri2922  0.308
2011 van Diepen JA, Wong MC, Guigas B, Bos J, Stienstra R, Hodson L, Shoelson SE, Berbée JF, Rensen PC, Romijn JA, Havekes LM, Voshol PJ. Hepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE*3-Leiden mice. Journal of Lipid Research. 52: 942-50. PMID 21357939 DOI: 10.1194/Jlr.M010405  0.363
2011 Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nature Reviews. Immunology. 11: 98-107. PMID 21233852 DOI: 10.1038/Nri2925  0.385
2011 Goldfine AB, Fonseca V, Shoelson SE. Therapeutic approaches to target inflammation in type 2 diabetes. Clinical Chemistry. 57: 162-7. PMID 21098138 DOI: 10.1373/Clinchem.2010.148833  0.416
2010 Herrero L, Shapiro H, Nayer A, Lee J, Shoelson SE. Inflammation and adipose tissue macrophages in lipodystrophic mice. Proceedings of the National Academy of Sciences of the United States of America. 107: 240-5. PMID 20007767 DOI: 10.1073/Pnas.0905310107  0.819
2009 Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, Lee J, Goldfine AB, Benoist C, Shoelson S, Mathis D. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nature Medicine. 15: 930-9. PMID 19633656 DOI: 10.1038/Nm.2002  0.813
2009 Shoelson SE, Goldfine AB. Getting away from glucose: fanning the flames of obesity-induced inflammation. Nature Medicine. 15: 373-4. PMID 19350009 DOI: 10.1038/Nm0409-373  0.445
2008 Goldfine AB, Silver R, Aldhahi W, Cai D, Tatro E, Lee J, Shoelson SE. Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clinical and Translational Science. 1: 36-43. PMID 19337387 DOI: 10.1111/J.1752-8062.2008.00026.X  0.801
2008 Park SY, Shoelson SE. When a domain is not a domain. Nature Structural & Molecular Biology. 15: 224-6. PMID 18319738 DOI: 10.1038/Nsmb0308-224  0.396
2008 Fleischman A, Shoelson SE, Bernier R, Goldfine AB. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care. 31: 289-94. PMID 17959861 DOI: 10.2337/Dc07-1338  0.442
2007 Abedini A, Shoelson SE. Inflammation and obesity: STAMPing out insulin resistance? Immunology and Cell Biology. 85: 399-400. PMID 17646847 DOI: 10.1038/Sj.Icb.7100107  0.459
2007 Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 132: 2169-80. PMID 17498510 DOI: 10.1053/J.Gastro.2007.03.059  0.474
2007 Shoelson SE. Point-counterpoint: Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis. Journal of Applied Physiology (Bethesda, Md. : 1985). 102: 820; author reply 82. PMID 17323463  0.339
2007 Shoelson SE. Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis [2] Journal of Applied Physiology. 102: 820. DOI: 10.1152/japplphysiol.01353.2006  0.343
2006 Shoelson SE. Banking on ATM as a new target in metabolic syndrome. Cell Metabolism. 4: 337-8. PMID 17084707 DOI: 10.1016/J.Cmet.2006.10.009  0.4
2006 Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. The Journal of Clinical Investigation. 116: 1793-801. PMID 16823477 DOI: 10.1172/Jci29069  0.821
2005 Ho RC, Hirshman MF, Li Y, Cai D, Farmer JR, Aschenbach WG, Witczak CA, Shoelson SE, Goodyear LJ. Regulation of IkappaB kinase and NF-kappaB in contracting adult rat skeletal muscle. American Journal of Physiology. Cell Physiology. 289: C794-801. PMID 15888549 DOI: 10.1152/Ajpcell.00632.2004  0.614
2005 Nishi M, Werner ED, Oh BC, Frantz JD, Dhe-Paganon S, Hansen L, Lee J, Shoelson SE. Kinase activation through dimerization by human SH2-B. Molecular and Cellular Biology. 25: 2607-21. PMID 15767667 DOI: 10.1128/Mcb.25.7.2607-2621.2005  0.765
2005 Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nature Medicine. 11: 183-90. PMID 15685173 DOI: 10.1038/Nm1166  0.797
2004 Cai D, Frantz JD, Tawa NE, Melendez PA, Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ, Shoelson SE. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell. 119: 285-98. PMID 15479644 DOI: 10.1016/J.Cell.2004.09.027  0.747
2004 Dhe-Paganon S, Werner ED, Nishi M, Hansen L, Chi YI, Shoelson SE. A phenylalanine zipper mediates APS dimerization. Nature Structural & Molecular Biology. 11: 968-74. PMID 15378031 DOI: 10.1038/Nsmb829  0.366
2004 Werner ED, Lee J, Hansen L, Yuan M, Shoelson SE. Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302. The Journal of Biological Chemistry. 279: 35298-305. PMID 15199052 DOI: 10.1074/Jbc.M405203200  0.817
2003 Shoelson SE, Lee J, Yuan M. Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association For the Study of Obesity. 27: S49-52. PMID 14704745 DOI: 10.1038/Sj.Ijo.0802501  0.524
2003 Cai D, Dhe-Paganon S, Melendez PA, Lee J, Shoelson SE. Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5. The Journal of Biological Chemistry. 278: 25323-30. PMID 12730241 DOI: 10.1074/Jbc.M212430200  0.814
2003 Kim KA, Kang K, Chi YI, Chang I, Lee MK, Kim KW, Shoelson SE, Lee MS. Identification and functional characterization of a novel mutation of hepatocyte nuclear factor-1alpha gene in a Korean family with MODY3. Diabetologia. 46: 721-7. PMID 12712243 DOI: 10.1007/S00125-003-1079-7  0.358
2003 Wick KR, Werner ED, Langlais P, Ramos FJ, Dong LQ, Shoelson SE, Liu F. Grb10 inhibits insulin-stimulated insulin receptor substrate (IRS)-phosphatidylinositol 3-kinase/Akt signaling pathway by disrupting the association of IRS-1/IRS-2 with the insulin receptor. The Journal of Biological Chemistry. 278: 8460-7. PMID 12493740 DOI: 10.1074/Jbc.M208518200  0.485
2002 Rui L, Yuan M, Frantz D, Shoelson S, White MF. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2 Journal of Biological Chemistry. 277: 42394-42398. PMID 12228220 DOI: 10.1074/Jbc.C200444200  0.505
2002 Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, Shulman GI. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. The Journal of Clinical Investigation. 109: 1321-6. PMID 12021247 DOI: 10.1172/Jci14955  0.464
2002 Menzaghi C, Plengvidhya N, Ma X, Warram JH, Shoelson SE, Doria A. Genetic variability in insulin action inhibitor Ikkbeta (IKBKB) does not play a major role in the development of type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism. 87: 1894-7. PMID 11932336 DOI: 10.1210/Jcem.87.4.8440  0.345
2002 Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. The Journal of Biological Chemistry. 277: 1531-7. PMID 11606564 DOI: 10.1074/Jbc.M101521200  0.41
2001 Netea MG, Tack CJ, Netten PM, Lutterman JA, Van der Meer JWM, Kim JK, Shoelson SE, Shulman GI. The effect of salicylates on insulin sensitivity (multiple letters) Journal of Clinical Investigation. 108: 1723-1724. PMID 11733568  0.363
2001 Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science (New York, N.Y.). 293: 1673-7. PMID 11533494 DOI: 10.1126/Science.1061620  0.532
2001 Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE, Shulman GI. Prevention of fat-induced insulin resistance by salicylate. The Journal of Clinical Investigation. 108: 437-46. PMID 11489937 DOI: 10.1172/Jci11559  0.507
2000 Lindholm CK, Frantz JD, Shoelson SE, Welsh M. Shf, a Shb-like adapter protein, is involved in PDGF-alpha-receptor regulation of apoptosis. Biochemical and Biophysical Research Communications. 278: 537-43. PMID 11095946 DOI: 10.1006/Bbrc.2000.3847  0.328
1999 Dhe-Paganon S, Ottinger EA, Nolte RT, Eck MJ, Shoelson SE. Crystal structure of the pleckstrin homology-phosphotyrosine binding (PH-PTB) targeting region of insulin receptor substrate 1. Proceedings of the National Academy of Sciences of the United States of America. 96: 8378-83. PMID 10411883 DOI: 10.1073/Pnas.96.15.8378  0.356
1998 Bjørbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS. Identification of SOCS-3 as a potential mediator of central leptin resistance. Molecular Cell. 1: 619-25. PMID 9660946 DOI: 10.1016/S1097-2765(00)80062-3  0.379
1998 Welsh M, Songyang Z, Frantz JD, Trüb T, Reedquist KA, Karlsson T, Miyazaki M, Cantley LC, Band H, Shoelson SE. Stimulation through the T cell receptor leads to interactions between SHB and several signaling proteins. Oncogene. 16: 891-901. PMID 9484780 DOI: 10.1038/Sj.Onc.1201607  0.353
1998 Ottinger EA, Botfield MC, Shoelson SE. Tandem SH2 domains confer high specificity in tyrosine kinase signaling. The Journal of Biological Chemistry. 273: 729-35. PMID 9422724 DOI: 10.1074/Jbc.273.2.729  0.369
1997 Shoelson SE. SH2 and PTB domain interactions in tyrosine kinase signal transduction. Current Opinion in Chemical Biology. 1: 227-34. PMID 9667855 DOI: 10.1016/S1367-5931(97)80014-2  0.323
1997 Lupher ML, Songyang Z, Shoelson SE, Cantley LC, Band H. The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70. The Journal of Biological Chemistry. 272: 33140-4. PMID 9407100 DOI: 10.1074/Jbc.272.52.33140  0.315
1997 Lee J, Pilch PF, Shoelson SE, Scarlata SF. Conformational changes of the insulin receptor upon insulin binding and activation as monitored by fluorescence spectroscopy. Biochemistry. 36: 2701-8. PMID 9054578 DOI: 10.1021/Bi961815G  0.657
1997 Giorgetti-Peraldi S, Ottinger E, Wolf G, Ye B, Burke TR, Shoelson SE. Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking. Molecular and Cellular Biology. 17: 1180-8. PMID 9032245 DOI: 10.1128/Mcb.17.3.1180  0.487
1997 Frantz JD, Giorgetti-Peraldi S, Ottinger EA, Shoelson SE. Human GRB-IRbeta/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains. The Journal of Biological Chemistry. 272: 2659-67. PMID 9006901 DOI: 10.1074/Jbc.272.5.2659  0.456
1997 Trüb T, Frantz JD, Miyazaki M, Band H, Shoelson SE. The role of a lymphoid-restricted, Grb2-like SH3-SH2-SH3 protein in T cell receptor signaling. The Journal of Biological Chemistry. 272: 894-902. PMID 8995379 DOI: 10.1074/Jbc.272.2.894  0.346
1996 Ricketts WA, Rose DW, Shoelson S, Olefsky JM. Functional roles of the Shc phosphotyrosine binding and Src homology 2 domains in insulin and epidermal growth factor signaling Journal of Biological Chemistry. 271: 26165-26169. PMID 8824262 DOI: 10.1074/Jbc.271.42.26165  0.399
1996 Eck MJ, Dhe-Paganon S, Trüb T, Nolte RT, Shoelson SE. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell. 85: 695-705. PMID 8646778 DOI: 10.1016/S0092-8674(00)81236-2  0.437
1996 Reedquist KA, Fukazawa T, Panchamoorthy G, Langdon WY, Shoelson SE, Druker BJ, Band H. Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G. The Journal of Biological Chemistry. 271: 8435-42. PMID 8626543 DOI: 10.1074/Jbc.271.14.8435  0.326
1996 Zhou MM, Huang B, Olejniczak ET, Meadows RP, Shuker SB, Miyazaki M, Trüb T, Shoelson SE, Fesik SW. Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain. Nature Structural Biology. 3: 388-93. PMID 8599766 DOI: 10.1038/Nsb0496-388  0.37
1996 Nolte RT, Eck MJ, Schlessinger J, Shoelson SE, Harrison SC. Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes. Nature Structural Biology. 3: 364-74. PMID 8599763 DOI: 10.1038/Nsb0496-364  0.306
1996 Eck MJ, Pluskey S, Trüb T, Harrison SC, Shoelson SE. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2. Nature. 379: 277-80. PMID 8538796 DOI: 10.1038/379277A0  0.34
1995 Lee J, Shoelson SE, Pilch PF. Intermolecular phosphorylation between insulin holoreceptors does not stimulate substrate kinase activity. The Journal of Biological Chemistry. 270: 31136-40. PMID 8537376 DOI: 10.1074/Jbc.270.52.31136  0.671
1995 Yamada K, Carpentier JL, Cheatham B, Goncalves E, Shoelson SE, Kahn CR. Role of the transmembrane domain and flanking amino acids in internalization and down-regulation of the insulin receptor. The Journal of Biological Chemistry. 270: 3115-22. PMID 7852393 DOI: 10.1074/Jbc.270.7.3115  0.429
1995 Yamada K, Goncalves E, Carpentier JL, Kahn CR, Shoelson SE. Transmembrane domain inversion blocks ER release and insulin receptor signaling. Biochemistry. 34: 946-54. PMID 7827053 DOI: 10.1021/Bi00003A029  0.447
1995 Schneider H, Prasad KV, Shoelson SE, Rudd CE. CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. The Journal of Experimental Medicine. 181: 351-5. PMID 7807015 DOI: 10.1084/Jem.181.1.351  0.329
1995 Fukazawa T, Reedquist KA, Trub T, Soltoff S, Panchamoorthy G, Druker B, Cantley L, Shoelson SE, Band H. The SH3 domain-binding T cell tyrosyl phosphoprotein p120. Demonstration of its identity with the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase. The Journal of Biological Chemistry. 270: 19141-50. PMID 7642581 DOI: 10.1074/Jbc.270.32.19141  0.34
1995 Fukazawa T, Reedquist KA, Panchamoorthy G, Soltoff S, Trub T, Druker B, Cantley L, Shoelson SE, Band H. T cell activation-dependent association between the p85 subunit of the phosphatidylinositol 3-kinase and Grb2/phospholipase C-gamma 1-binding phosphotyrosyl protein pp36/38. The Journal of Biological Chemistry. 270: 20177-82. PMID 7544353 DOI: 10.1074/Jbc.270.34.20177  0.334
1995 Trüb T, Choi WE, Wolf G, Ottinger E, Chen Y, Weiss M, Shoelson SE. Specificity of the PTB domain of Shc for beta turn-forming pentapeptide motifs amino-terminal to phosphotyrosine. The Journal of Biological Chemistry. 270: 18205-8. PMID 7543098 DOI: 10.1074/Jbc.270.31.18205  0.337
1995 van der Geer P, Wiley S, Lai VK, Olivier JP, Gish GD, Stephens R, Kaplan D, Shoelson S, Pawson T. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides. Current Biology : Cb. 5: 404-12. PMID 7542991 DOI: 10.1016/S0960-9822(95)00081-9  0.335
1995 Pluskey S, Wandless TJ, Walsh CT, Shoelson SE. Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains. The Journal of Biological Chemistry. 270: 2897-900. PMID 7531695 DOI: 10.1074/Jbc.270.7.2897  0.319
1995 Ravichandran KS, Lorenz U, Shoelson SE, Burakoff SJ. Interaction of Shc with Grb2 regulates association of Grb2 with mSOS. Molecular and Cellular Biology. 15: 593-600. PMID 7529871 DOI: 10.1128/Mcb.15.2.593  0.343
1995 Wolf G, Trüb T, Ottinger E, Groninga L, Lynch A, White MF, Miyazaki M, Lee J, Shoelson SE. PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities. The Journal of Biological Chemistry. 270: 27407-10. PMID 7499194 DOI: 10.1074/Jbc.270.46.27407  0.389
1994 Payne G, Stolz LA, Pei D, Band H, Shoelson SE, Walsh CT. The phosphopeptide-binding specificity of Src family SH2 domains. Chemistry & Biology. 1: 99-105. PMID 9383377 DOI: 10.1016/1074-5521(94)90047-7  0.317
1994 Prasad KV, Cai YC, Raab M, Duckworth B, Cantley L, Shoelson SE, Rudd CE. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proceedings of the National Academy of Sciences of the United States of America. 91: 2834-8. PMID 8146197 DOI: 10.1073/Pnas.91.7.2834  0.324
1994 Li SC, Deber CM, Shoelson SE. An irregularity in the transmembrane domain helix correlates with the rate of insulin receptor internalization. Biochemistry. 33: 14333-8. PMID 7947843 DOI: 10.1021/Bi00251A047  0.383
1994 Lee CH, Kominos D, Jacques S, Margolis B, Schlessinger J, Shoelson SE, Kuriyan J. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. Structure (London, England : 1993). 2: 423-38. PMID 7521735 DOI: 10.1016/S0969-2126(00)00044-7  0.302
1994 Panchamoorthy G, Fukazawa T, Stolz L, Payne G, Reedquist K, Shoelson S, Songyang Z, Cantley L, Walsh C. Physical and functional interactions between SH2 and SH3 domains of the Src family protein tyrosine kinase p59fyn. Molecular and Cellular Biology. 14: 6372-6385. PMID 7520528 DOI: 10.1128/mcb.14.9.6372-6385.1994  0.31
1994 Burke TR, Smyth MS, Otaka A, Nomizu M, Roller PP, Wolf G, Case R, Shoelson SE. Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors. Biochemistry. 33: 6490-4. PMID 7515682 DOI: 10.1021/Bi00187A015  0.311
1994 Reedquist KA, Fukazawa T, Druker B, Panchamoorthy G, Shoelson SE, Band H. Rapid T-cell receptor-mediated tyrosine phosphorylation of p120, an Fyn/Lck Src homology 3 domain-binding protein. Proceedings of the National Academy of Sciences of the United States of America. 91: 4135-9. PMID 7514295 DOI: 10.1073/Pnas.91.10.4135  0.337
1994 Eck MJ, Atwell SK, Shoelson SE, Harrison SC. Structure of the regulatory domains of the Src-family tyrosine kinase Lck. Nature. 368: 764-9. PMID 7512222 DOI: 10.1038/368764A0  0.313
1994 Songyang Z, Shoelson SE, McGlade J, Olivier P, Pawson T, Bustelo XR, Barbacid M, Sabe H, Hanafusa H, Yi T. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Molecular and Cellular Biology. 14: 2777-85. PMID 7511210 DOI: 10.1128/Mcb.14.4.2777  0.306
1994 Roller PP, Otaka A, Nomizu M, Smyth MS, Barchi JJ, Burke TR, Case RD, Wolf G, Shoelson SE. Norleucine as a replacement for methionine in phosphatase-resistant linear and cyclic peptides which bind to p85 SH2 domains Bioorganic and Medicinal Chemistry Letters. 4: 1879-1882. DOI: 10.1016/S0960-894X(01)80389-9  0.307
1993 Lee J, O'Hare T, Pilch PF, Shoelson SE. Insulin receptor autophosphorylation occurs asymmetrically. The Journal of Biological Chemistry. 268: 4092-8. PMID 8440700  0.637
1993 Hua QX, Shoelson SE, Inouye K, Weiss MA. Paradoxical structure and function in a mutant human insulin associated with diabetes mellitus. Proceedings of the National Academy of Sciences of the United States of America. 90: 582-6. PMID 8421693 DOI: 10.1073/Pnas.90.2.582  0.508
1993 Chuang LM, Myers MG, Backer JM, Shoelson SE, White MF, Birnbaum MJ, Kahn CR. Insulin-stimulated oocyte maturation requires insulin receptor substrate 1 and interaction with the SH2 domains of phosphatidylinositol 3-kinase. Molecular and Cellular Biology. 13: 6653-60. PMID 8413261 DOI: 10.1128/Mcb.13.11.6653  0.455
1993 Goncalves E, Yamada K, Thatte HS, Backer JM, Golan DE, Kahn CR, Shoelson SE. Optimizing transmembrane domain helicity accelerates insulin receptor internalization and lateral mobility. Proceedings of the National Academy of Sciences of the United States of America. 90: 5762-6. PMID 8390680 DOI: 10.1073/Pnas.90.12.5762  0.433
1993 Backer JM, Myers MG, Sun XJ, Chin DJ, Shoelson SE, Miralpeix M, White MF. Association of IRS-1 with the insulin receptor and the phosphatidylinositol 3'-kinase. Formation of binary and ternary signaling complexes in intact cells. The Journal of Biological Chemistry. 268: 8204-12. PMID 8385139  0.377
1993 Piccione E, Case RD, Domchek SM, Hu P, Chaudhuri M, Backer JM, Schlessinger J, Shoelson SE. Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding. Biochemistry. 32: 3197-202. PMID 8384875 DOI: 10.1021/Bi00064A001  0.309
1993 Shoelson SE, Lee J, Lynch CS, Backer JM, Pilch PF. BpaB25 insulins. Photoactivatable analogues that quantitatively cross-link, radiolabel, and activate the insulin receptor. The Journal of Biological Chemistry. 268: 4085-91. PMID 8382690  0.658
1993 Shoelson SE, Sivaraja M, Williams KP, Hu P, Schlessinger J, Weiss MA. Specific phosphopeptide binding regulates a conformational change in the PI 3-kinase SH2 domain associated with enzyme activation. The Embo Journal. 12: 795-802. PMID 8382612 DOI: 10.1002/J.1460-2075.1993.Tb05714.X  0.363
1993 Castaño L, Ziegler AG, Ziegler R, Shoelson S, Eisenbarth GS. Characterization of Insulin Autoantibodies in Relatives of Patients With Type I Diabetes Diabetes. 42: 1202-1209. PMID 8325453 DOI: 10.2337/Diab.42.8.1202  0.501
1993 Williams KP, Shoelson SE. Cooperative self-assembly of SH2 domain fragments restores phosphopeptide binding. Biochemistry. 32: 11279-84. PMID 7692962 DOI: 10.1021/Bi00093A003  0.302
1993 Cheatham B, Shoelson SE, Yamada K, Goncalves E, Kahn CR. Substitution of the erbB-2 oncoprotein transmembrane domain activates the insulin receptor and modulates the action of insulin and insulin-receptor substrate 1. Proceedings of the National Academy of Sciences of the United States of America. 90: 7336-40. PMID 7688476 DOI: 10.1073/Pnas.90.15.7336  0.503
1993 Payne G, Shoelson SE, Gish GD, Pawson T, Walsh CT. Kinetics of p56lck and p60src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance. Proceedings of the National Academy of Sciences of the United States of America. 90: 4902-6. PMID 7685110 DOI: 10.1073/Pnas.90.11.4902  0.35
1993 Eck MJ, Shoelson SE, Harrison SC. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck. Nature. 362: 87-91. PMID 7680435 DOI: 10.1038/362087A0  0.31
1993 Kahn CR, White MF, Shoelson SE, Backer JM, Araki E, Cheatham B, Csermely P, Folli F, Goldstein BJ, Huertas P. The insulin receptor and its substrate: molecular determinants of early events in insulin action. Recent Progress in Hormone Research. 48: 291-339. PMID 7680139 DOI: 10.1016/B978-0-12-571148-7.50015-4  0.488
1993 Felder S, Zhou M, Hu P, Ureña J, Ullrich A, Chaudhuri M, White M, Shoelson SE, Schlessinger J. SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange. Molecular and Cellular Biology. 13: 1449-55. PMID 7680095 DOI: 10.1128/Mcb.13.3.1449  0.36
1992 Shoelson SE, Lu ZX, Parlautan L, Lynch CS, Weiss MA. Mutations at the dimer, hexamer, and receptor-binding surfaces of insulin independently affect insulin-insulin and insulin-receptor interactions. Biochemistry. 31: 1757-67. PMID 1737029 DOI: 10.1021/Bi00121A025  0.508
1992 Backer JM, Shoelson SE, Weiss MA, Hua QX, Cheatham RB, Haring E, Cahill DC, White MF. The insulin receptor juxtamembrane region contains two independent tyrosine/beta-turn internalization signals. The Journal of Cell Biology. 118: 831-9. PMID 1500426 DOI: 10.1083/Jcb.118.4.831  0.454
1992 Hua QX, Shoelson SE, Weiss MA. Nonlocal structural perturbations in a mutant human insulin: sequential resonance assignment and 13C-isotope-aided 2D-NMR studies of [PheB24-->Gly]insulin with implications for receptor recognition. Biochemistry. 31: 11940-51. PMID 1445924 DOI: 10.1021/Bi00162A037  0.45
1992 Meyerovitch J, Backer JM, Csermely P, Shoelson SE, Kahn CR. Insulin differentially regulates protein phosphotyrosine phosphatase activity in rat hepatoma cells. Biochemistry. 31: 10338-44. PMID 1420153 DOI: 10.1021/Bi00157A023  0.456
1992 Domchek SM, Auger KR, Chatterjee S, Burke TR, Shoelson SE. Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide. Biochemistry. 31: 9865-70. PMID 1382595 DOI: 10.1021/Bi00156A002  0.319
1992 Backer JM, Myers MG, Shoelson SE, Chin DJ, Sun XJ, Miralpeix M, Hu P, Margolis B, Skolnik EY, Schlessinger J. Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation. The Embo Journal. 11: 3469-79. PMID 1380456 DOI: 10.1002/J.1460-2075.1992.Tb05426.X  0.411
1992 Yamada K, Goncalves E, Kahn CR, Shoelson SE. Substitution of the insulin receptor transmembrane domain with the c-neu/erbB2 transmembrane domain constitutively activates the insulin receptor kinase in vitro. The Journal of Biological Chemistry. 267: 12452-61. PMID 1352286  0.396
1992 Myers MG, Backer JM, Sun XJ, Shoelson S, Hu P, Schlessinger J, Yoakim M, Schaffhausen B, White MF. IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85. Proceedings of the National Academy of Sciences of the United States of America. 89: 10350-4. PMID 1332046 DOI: 10.1073/Pnas.89.21.10350  0.417
1992 Shoelson SE, Chatterjee S, Chaudhuri M, White MF. YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase. Proceedings of the National Academy of Sciences of the United States of America. 89: 2027-31. PMID 1312712 DOI: 10.1073/Pnas.89.6.2027  0.451
1991 Hua QX, Shoelson SE, Kochoyan M, Weiss MA. Receptor binding redefined by a structural switch in a mutant human insulin. Nature. 354: 238-41. PMID 1961250 DOI: 10.1038/354238A0  0.486
1991 Weiss MA, Hua QX, Lynch CS, Frank BH, Shoelson SE. Heteronuclear 2D NMR studies of an engineered insulin monomer: assignment and characterization of the receptor-binding surface by selective 2H and 13C labeling with application to protein design. Biochemistry. 30: 7373-89. PMID 1906742 DOI: 10.1021/Bi00244A004  0.469
1991 Backer JM, Shoelson SE, Haring E, White MF. Insulin receptors internalize by a rapid, saturable pathway requiring receptor autophosphorylation and an intact juxtamembrane region. The Journal of Cell Biology. 115: 1535-45. PMID 1757462 DOI: 10.1083/Jcb.115.6.1535  0.487
1991 Shoelson SE, Boni-Schnetzler M, Pilch PF, Kahn CR. Autophosphorylation within insulin receptor beta-subunits can occur as an intramolecular process. Biochemistry. 30: 7740-6. PMID 1651107 DOI: 10.1021/bi00245a010  0.589
1990 Weiss MA, Frank BH, Khait I, Pekar A, Heiney R, Shoelson SE, Neuringer LJ. NMR and photo-CIDNP studies of human proinsulin and prohormone processing intermediates with application to endopeptidase recognition. Biochemistry. 29: 8389-401. PMID 2252901 DOI: 10.1021/Bi00488A028  0.437
1989 Weiss MA, Nguyen DT, Khait I, Inouye K, Frank BH, Beckage M, O'Shea E, Shoelson SE, Karplus M, Neuringer LJ. Two-dimensional NMR and photo-CIDNP studies of the insulin monomer: assignment of aromatic resonances with application to protein folding, structure, and dynamics. Biochemistry. 28: 9855-73. PMID 2692717 DOI: 10.1021/Bi00451A046  0.422
1988 Karasik A, Pepinsky RB, Shoelson SE, Kahn CR. Lipocortins 1 and 2 as substrates for the insulin receptor kinase in rat liver. The Journal of Biological Chemistry. 263: 11862-7. PMID 2457028  0.34
1988 White MF, Shoelson SE, Keutmann H, Kahn CR. A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. The Journal of Biological Chemistry. 263: 2969-80. PMID 2449432  0.304
1986 Shoelson SE, Polonsky KS, Nakabayashi T, Jaspan JB, Tager HS. Circulating forms of somatostatinlike immunoreactivity in human plasma. The American Journal of Physiology. 250: E428-34. PMID 3963183 DOI: 10.1152/Ajpendo.1986.250.4.E428  0.643
1986 Halban PA, Rhodes CJ, Shoelson SE. High-performance liquid chromatography (HPLC): a rapid, flexible and sensitive method for separating islet proinsulin and insulin. Diabetologia. 29: 893-6. PMID 3552815 DOI: 10.1007/Bf00870146  0.443
1986 Shoelson SE, Marshall S, Horikoshi H, Kolterman OG, Rubenstein AH, Olefsky JM. Antiinsulin receptor antibodies in an insulin-dependent diabetic may arise as autoantiidiotypes. The Journal of Clinical Endocrinology and Metabolism. 63: 56-61. PMID 3486878 DOI: 10.1210/Jcem-63-1-56  0.689
1985 Given BD, Cohen RM, Shoelson SE, Frank BH, Rubenstein AH, Tager HS. Biochemical and clinical implications of proinsulin conversion intermediates. The Journal of Clinical Investigation. 76: 1398-405. PMID 3902891 DOI: 10.1172/Jci112116  0.759
1985 Robbins DC, Shoelson SE, Tager HS, Mead PM, Gaynor DH. Products of therapeutic insulins in the blood of insulin-dependent (type I) diabetic patients. Diabetes. 34: 510-9. PMID 3886464 DOI: 10.2337/Diab.34.5.510  0.7
1985 Cohen RM, Nakabayashi T, Blix PM, Rue PA, Shoelson SE, Root MA, Frank BH, Revers RR, Rubenstein AH. A radioimmunoassay for circulating human proinsulin. Diabetes. 34: 84-91. PMID 3880551 DOI: 10.2337/Diab.34.1.84  0.664
1984 Haneda M, Polonsky KS, Bergenstal RM, Jaspan JB, Shoelson SE, Blix PM, Chan SJ, Kwok SC, Wishner WB, Zeidler A. Familial hyperinsulinemia due to a structurally abnormal insulin. Definition of an emerging new clinical syndrome. The New England Journal of Medicine. 310: 1288-94. PMID 6371526 DOI: 10.1056/NEJM198405173102004  0.629
1984 Shoelson SE, Polonsky KS, Zeidler A, Rubenstein AH, Tager HS. Human insulin B24 (Phe----Ser). Secretion and metabolic clearance of the abnormal insulin in man and in a dog model. The Journal of Clinical Investigation. 73: 1351-8. PMID 6371057 DOI: 10.1172/Jci111338  0.817
1984 Robbins DC, Shoelson SE, Rubenstein AH, Tager HS. Familial hyperproinsulinemia. Two cohorts secreting indistinguishable type II intermediates of proinsulin conversion. The Journal of Clinical Investigation. 73: 714-9. PMID 6368587 DOI: 10.1172/Jci111264  0.741
1983 Shoelson S, Fickova M, Haneda M, Nahum A, Musso G, Kaiser ET, Rubenstein AH, Tager H. Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution. Proceedings of the National Academy of Sciences of the United States of America. 80: 7390-4. PMID 6424111 DOI: 10.1073/Pnas.80.24.7390  0.789
1983 Shoelson S, Haneda M, Blix P, Nanjo A, Sanke T, Inouye K, Steiner D, Rubenstein A, Tager H. Three mutant insulins in man Nature. 302: 540-543. PMID 6339950 DOI: 10.1038/302540A0  0.79
1983 Polonsky KS, Shoelson SE, Docherty HM. Plasma somatostatin 28 increases in response to feeding in man. The Journal of Clinical Investigation. 71: 1514-8. PMID 6133883 DOI: 10.1172/Jci110907  0.5
1982 Shoelson S, Polonsky K, Docherty H, Jaspan J, Rubenstein A. Evidence for the presence of somatostatin 28 in plasma Diabetes. 31: 474-477. PMID 6130021 DOI: 10.2337/Diab.31.5.474  0.589
Show low-probability matches.